Med Fusion, acquired by Quest Diagnostics on July 21, 2017, operates as an integrated Molecular Center of Excellence and clinical trials organization. The company provides advanced laboratory diagnostics and comprehensive support services to healthcare providers and biotech pharmaceutical companies. Med Fusion's full-service clinical laboratory includes a dedicated team for test development and validation, as well as reference lab services such as pathology and molecular response testing.

Med Fusion serves a diverse range of clients, primarily focusing on healthcare providers and biotech firms that require precise and reliable diagnostic services. The company operates within the healthcare and biotechnology markets, leveraging its expertise to meet the specific needs of these sectors.

The business model of Med Fusion revolves around offering specialized diagnostic services and clinical trial support. Revenue is generated through service contracts with healthcare providers and biotech companies, who rely on Med Fusion's advanced laboratory capabilities to enhance patient care and accelerate drug development processes.

Keywords: molecular diagnostics, clinical trials, healthcare providers, biotech firms, test development, validation, pathology, molecular response, laboratory services, precision medicine.